GCT Breakthroughs Focus of World Forum May 19-21

Gene and cell therapy (GCT), a transformative approach to develop treatments, and, potentially, cures for congenital and other diseases, is the focus of this year’s World Medical Innovation Forum May 19-21.

Read more: https://www.massgeneralbrigham.org/newsroom/press-releases/gene-and-cell-therapy-breakthroughs-focus-world-medical-innovation-forum

Most Recent Posts:

Doctor showing a patient information on a touchscreen device

The Medically Engineered Solutions in Healthcare (MESH) Incubator: A case study of innovation “push”

In an opinion piece for STAT, Marc Succi, MD, Clinician-in-Residence at Mass General Brigham Innovation, addresses the…

Read More
WMIF 2022 Recap

2022 World Medical Innovation Forum | Day 3 Recap

The final day of the World Medical Innovation Forum began with a discussion on the fast-moving landscape…

Read More
WMIF 2022 Recap

2022 World Medical Innovation Forum | Day 2 Recap

Day 2 of World Medical Innovation Forum kicked off with a fireside chat with FDA commissioner Robert…

Read More